| Date | Time | Source | Headline | Symbol | Company |
| 06/21/2006 | 5:05PM | PR Newswire (US) | Corgentech Changes Name to Anesiva to Reflect Focus on Robust Pipeline of Pain Therapeutics | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 06/20/2006 | 8:00AM | PR Newswire (US) | Corgentech Secures $30 Million Committed Equity Financing Facility | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 06/14/2006 | 8:00AM | PR Newswire (US) | Corgentech Pain Drug, 4975, Demonstrates Statistically Significant Pain Reduction After Knee Replacement Surgeries | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 06/07/2006 | 8:00AM | PR Newswire (US) | Corgentech to Present at Pacific Growth Equities Life Sciences Growth Conference and Needham & Company Fifth Annual Biotechnolo | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 06/06/2006 | 8:00AM | PR Newswire (US) | Corgentech Announces Appointment of K. Peony Yu as Vice President, Clinical Research and Michael Leong as Director, Clinical Re | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 05/30/2006 | 8:30AM | PR Newswire (US) | Corgentech Announces Appointment of Susan Kramer as Vice President of Preclinical Development | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 05/22/2006 | 3:00PM | PR Newswire (US) | Corgentech to Host Webcast Conference Call on Wednesday, May 24, 2006 | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 05/18/2006 | 8:30AM | PR Newswire (US) | Corgentech Announces Scientific Presentation of Pivotal Phase 3 Data Demonstrating Significant Pain Reduction Associated With F | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 05/04/2006 | 5:02PM | PR Newswire (US) | Corgentech Announces First Quarter 2006 Financial Results | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 05/04/2006 | 8:30AM | PR Newswire (US) | Corgentech Presents Additional Phase 2 Data Demonstrating 4975 Provides Early, Sustained Relief of Pain and improved function i | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 04/28/2006 | 8:30AM | PR Newswire (US) | Corgentech Announces Presentation of 3268 Phase 3 Data at 2006 Pediatric Academic Societies' Annual Meeting | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 04/27/2006 | 8:30AM | PR Newswire (US) | Corgentech to Announce First Quarter 2006 Financial Results and Host Webcast Conference Call on May 4, 2006 | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 04/17/2006 | 6:31PM | PR Newswire (US) | Corgentech Files Universal Shelf Registration | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 03/27/2006 | 8:00AM | PR Newswire (US) | Corgentech to Present at CIBC World Markets' Annual Biotechnology and Specialty Pharmaceuticals Conference 2006 | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 03/24/2006 | 4:05PM | PR Newswire (US) | Corgentech Reports Phase 2 Trial Results for 4975 in Hernia Repair Pain | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 03/09/2006 | 7:00AM | PR Newswire (US) | Corgentech Phase 2 Trial of ALGRX 4975 Meets Primary Endpoint of Decreased Pain for Tendonitis Patients | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 03/06/2006 | 7:00AM | PR Newswire (US) | Corgentech Presents Clinical Data From Phase 1/2 Trial of Avrina(TM), Drug Candidate for Eczema | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 03/03/2006 | 7:00AM | PR Newswire (US) | Corgentech to Webcast Presentation From Lehman Brothers 2006 Global Healthcare Conference | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 02/24/2006 | 7:00AM | PR Newswire (US) | Corgentech to Webcast Presentation From 2006 Citigroup Global Health Care Conference | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 02/23/2006 | 4:05PM | PR Newswire (US) | Corgentech Announces Fourth Quarter and Year-End 2005 Financial Results | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 02/17/2006 | 4:05PM | PR Newswire (US) | Corgentech to Announce Fourth Quarter and Year-End 2005 Financial Results and Host Webcast Conference Call on February 23, 2006 | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 02/09/2006 | 7:00AM | PR Newswire (US) | Corgentech Completes Patient Enrollment in Three Phase 2 Clinical Trials of Post-Surgical Pain Drug Candidate | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 02/08/2006 | 7:00AM | PR Newswire (US) | Corgentech to Webcast Presentation From 2006 BIO CEO and Investor Conference | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 02/07/2006 | 5:00PM | PR Newswire (US) | Corgentech Reports Clinical Data From Phase 1/2 Trials of Avrina(TM), Drug Candidate for Eczema | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 01/19/2006 | 7:00AM | PR Newswire (US) | Corgentech Announces Management Promotions | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 12/16/2005 | 7:00AM | PR Newswire (US) | Corgentech and AlgoRx Complete Merger Creating Late-Stage Company Addressing Pain Management and Inflammation | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 12/06/2005 | 7:00AM | PR Newswire (US) | Corgentech and AlgoRx Complete Enrollment for Phase 1/2 Trial of Avrina(TM), New Drug Candidate for Eczema | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 11/22/2005 | 7:00AM | PR Newswire (US) | AlgoRx and Corgentech to Webcast Presentation From the Lazard Capital Markets 2005 Life Sciences Conference | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 11/17/2005 | 7:00AM | PR Newswire (US) | AlgoRx and Corgentech to Mail Definitive Proxy for Proposed Merger | NASDAQ:CGTK | Corgentech Inc. (MM) |
| 11/15/2005 | 7:00AM | PR Newswire (US) | AlgoRx and Corgentech Announce Addition of Ninth Board Member to Proposed Board of Directors for Combined Company | NASDAQ:CGTK | Corgentech Inc. (MM) |